CD.VCantex Mine Development Corp.
This year, CD.V has to prove it’s not just another junior miner with a nice story — it has to deliver. The next catalyst is the 2026 North Rackla Drill Program initial assays on October 15, which could push the stock to $0.38 if the mineralization confirms high-grade germanium, or drop it to $0.22 if the step-outs fail to expand the 2.65km strike. The company’s fate hinges on whether it can turn this massive sulphide project into a real asset, not just a spreadsheet.
The schedule
- Thu15Oct
First batch of assay results from the summer 2026 drilling at the massive sulphide project.
- Thu12Nov
Follow-up metallurgical optimization results targeting premium-grade lead, zinc, and germanium recoveries.
- Sat5Dec
Seasonal halt of Yukon field operations and the onset of the traditional micro-cap tax-loss selling period.
- Wed23Dec
Q3 financial results for the quarter ended October 31, 2026, capturing peak summer exploration spend.
- Tue29Dec
Release of Q2 financials for the period ended July 31, 2026, detailing cash burn and exploration expenditures.
- Mon15Feb
Announcement of the 2027 exploration roadmap and potential spring mobilization targets.
- Tue20Apr
Annual financial results for the year ended January 31, 2027.
Past
- Thu10Sep
Actual outcome: Bull
The stock closed at the bull target of $0.29, reflecting positive market sentiment following the final tranche of the $3M private placement. The completion of the funding round signaled progress in the company's capital-raising efforts, reinforcing investor confidence despite no additional earnings or guidance provided.
Expected closing of the remaining tranche of the $3M non-brokered private placement.